Cara Therapeutics (CARA) P/S US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
P/S | ? | 5.31 | 26.8 | 13.8 | 1.92 | 1.92 | 7.07 | ||
Changes by years, y/y, % | -85% | +405% | -49% | -86% | 0% | -43.9% |
Cara Therapeutics. P/S
Cara Therapeutics. P/S, changes, %
Cara Therapeutics (CARA) P/S US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/S | ? | 4.29 | 1.93 | 1.93 | 2.93 | 1.28 | 7.07 | |
Changes by years, y/y, % | -66% | -86% | -86% | -52% | -77% | |||
Changes by quarters, q/q, % | -24% | -55% | 0% | +52% | -56% |